Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 60,203 |
|
|||||
| News | - | ||||||
| Day High | 1.80 | Low High |
|||||
| Day Low | 1.72 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| iBio Inc | IBIO | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 2.33% | 1.76 | 17:44:36 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.77 | 1.72 | 1.80 | 1.76 | 1.72 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 454 | 60,203 | US$ 1.75 | US$ 105,460 | - | 1.0214 - 23.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 100 | US$ 1.76 | USD |
iBio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.13M | 3.48M | - | 0 | -65.01M | -18.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
iBio News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/27/2024 | 06:00 | GlobeNewswire Inc. | iBio and AstralBio Announce Transformative AI drug discovery.. |
| 3/26/2024 | 18:35 | GlobeNewswire Inc. | iBio Announces $15.0 Million Private Placement |
| 2/26/2024 | 06:59 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/26/2024 | 06:45 | GlobeNewswire Inc. | iBio Announces Sale of Preclinical PD-1 Agonist Antibody.. |
| 2/21/2024 | 15:55 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/19/2024 | 15:36 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/16/2024 | 07:15 | GlobeNewswire Inc. | iBio Announces Participation in 23rd Annual PepTalk.. |
| 1/10/2024 | 12:24 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 1/08/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/04/2024 | 07:00 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 12/26/2023 | 06:44 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/26/2023 | 06:15 | GlobeNewswire Inc. | iBio Amends and Extends Maturity of Credit Agreement |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IBIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.73 | 1.98 | 1.67 | 1.79 | 140,976 | 0.03 | 1.73% |
| 1 Month | 3.59 | 3.88 | 1.67 | 2.71 | 845,261 | -1.83 | -50.97% |
| 3 Months | 1.11 | 4.98 | 1.05 | 3.43 | 4,119,362 | 0.65 | 58.56% |
| 6 Months | 5.994 | 6.468 | 1.0214 | 3.41 | 2,063,285 | -4.23 | -70.64% |
| 1 Year | 23.60 | 23.60 | 1.0214 | 4.94 | 1,294,066 | -21.84 | -92.54% |
| 3 Years | 26.20 | 73.20 | 1.0214 | 18.49 | 2,738,858 | -24.44 | -93.28% |
| 5 Years | 16.12 | 157.00 | 1.00 | 36.27 | 6,827,635 | -14.36 | -89.08% |
iBio Description
| iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc. |
